Candesartan Cilexetil/Hydrochlorothiazide Treatment in High-Risk Patients with Type 2 Diabetes Mellitus and Microalbuminuria

2010 ◽  
Vol 30 (5) ◽  
pp. 301-311 ◽  
Author(s):  
Reinhard Ketelhut ◽  
Peter Bramlage
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
High Risk ◽  
Candesartan Cilexetil ◽  
High Risk Patients ◽  
Risk Patients

Dalcetrapib in High-Risk Patients with Type 2 Diabetes Mellitus and/or Metabolic Syndrome

2009 ◽  
Vol 3 (3) ◽  
pp. 223
Author(s):  
Michael H. Davidson ◽  
Anton F.H. Stalenhoef ◽  
Jennifer G. Robinson ◽  
Regina Duttlinger-Maddux ◽  
David Kallend ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Metabolic Syndrome ◽  
Type 2 Diabetes Mellitus ◽  
High Risk ◽  
High Risk Patients ◽  
Risk Patients

Lipid-Altering Efficacy of Ezetimibe/Simvastatin 10/20mg Compared with Rosuvastatin 10mg in High-Risk Patients with and Without Type 2 Diabetes Mellitus (T2DM)

2009 ◽  
Vol 3 (3) ◽  
pp. 233
Author(s):  
Philippe Brudi ◽  
Helena Vaverkova ◽  
Michel Farnier ◽  
Maurizio Averna ◽  
Margus Viigimaa ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
High Risk ◽  
High Risk Patients ◽  
Risk Patients

scholarly journals Cardiovascular prevention in high-risk patients with type 2 diabetes mellitus: when to start it?: reply

2008 ◽  
Vol 29 (16) ◽  
pp. 2058-2059
Author(s):  
L. G. Mellbin ◽  
L. Ryden ◽  
K. Malmberg ◽  
A. Norhammar ◽  
H. Wedel
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
High Risk ◽  
Cardiovascular Prevention ◽  
High Risk Patients ◽  
Risk Patients
Sign in / Sign up

Export Citation Format

Share Document